Sign in

NCT07905716Active, not recruiting

Comparative Effects of Sensorimotor Training and tACS on Upper Limb Function and Cervical Proprioception in Subacute Stroke

Comparative Effects of Sensorimotor Training and Transcranial Alternating Current Stimulation on Upper Extremity Functions, Sensorimotor Impairment and Cervical Joint Position Sense in Subacute Stroke Patients.

Source: ClinicalTrials.gov · Last updated 3 Nov 2026

Brief summary (registry, in English)

Stroke is leading cause of death and disability worldwide, resulting in significant functional limitations and disabilities experienced by stroke survivors. Stroke is an umbrella term that includes disorders such as cerebral infarction, cerebral hemorrhage, and subarachnoid hemorrhage.The aim of this study will be to compare the effects of sensorimotor training and transcranial alternating current stimulation on upper extremity functions, sensorimotor impairment and cervical joint position sense in sub-acute stroke patients. A single blinded randomized clinical trial will be used. Allocation will be concealed by sealed envelope. Non- probability convenient sampling will be done. On the basis of inclusion criteria participants will be randomly allocate in two groups (Group A and Group B) by using computer-generated software. Group A will receive sensorimotor training for 40 mins and TACS for 20 minutes at 2mA current, for 5 days/week for 4 weeks. Group B will receive sensorimotor training for 40 minutes and sham TACS for 20 minutes per session , for 5 days/week for 4 weeks . Measurements will be taken at baseline and at 4th week. Data will be collected using Fugyl meyer assessment scale, cervical joint position error test and revised Nottingham sensory assessment scale. Data analysis will be done by SPSS software version 27. The statistical software IBM SPSS Statistics SPSS 27 will be used for calculations. After assessing the normality by Shapiro-wilk test, if the p value is greater than 0.05 the data will be distributed normally, so parametric test will be applied. If p value is less than 0.05 than non-parametric test will be applied.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
38 (actual)
First submitted
23 Oct 2026
Start date
22 Oct 2026
Primary completion date
31 Dec 2026
Lead sponsor
University of Management and Technology Lahore
Diseases
Stroke
NCT number
NCT07905716

What you commit to

  • Study type: Interventional
  • Participants enrolled: 38
  • From 22 Oct 2026 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • presence of implants in the body

Other illness

  • history of seizures or epilepsy
  • Skin lesions or infection at electrode placement sites
  • Unstable cardiovascular condition

Other

  • Patients will be excluded if they will present with
  • use of a pacemaker

Who the study is looking for

  • Patients aged 45-60 years old
  • both genders
  • first-ever stroke (ischemic or haemorrhagic) confirmed by CT scan or MRI
  • subacute stage of stroke (1-6 months post stroke)
  • Mini mental state examination (MMSE) score \>24
  • Spasticity less than 2 by modified Ashworth scale (4)
  • National institute of health stroke scale (NIHSS) arm score should be \>1
  • Not receiving any other form of physiotherapy for upper limb (5)
  • Able to follow verbal instructions

Age in the registry: 45 years to 60 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Management & Technology
Coordinator of this site? Confirm its status
LahorePakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.